submit (1) the audited financial statements for the year 2021 and (2) the annual report for the year 2021 (Form 56-2, 2021) to the SEC within the specified period. This case is in the process of inquiry by
submit (1) the audited financial statements for the year 2021 and (2) the annual report for the year 2021 (Form 56-2, 2021) to the SEC within the specified period. This case is in the process of inquiry by
and submit (1) the audited financial statements for the year 2021 and (2) the annual report for the year 2021 (Form 56-2, 2021) to the SEC within the specified period. This case is in the process of
submit (1) the audited financial statements for the year 2021 and (2) the annual report for the year 2021 (Form 56-2, 2021) to the SEC within the specified period. This case is in the process of inquiry by
using the straight-line method for depreciation and apply the revised estimated useful lives for the financial statements of both consolidated and separated statements starting 1 January 2020. The details
capital increase/share allotment: 7.1 Dividend policy The Company has a dividend policy of at least 60% of its net profit after tax stated in the separate financial statements and after deduction for legal
regard, the company would like to report operating results for the second quarter of 2020 as follows Consolidated Financial Statements Ekachai Medical Care Public Company Limited and its subsidiaries
consideration loan applicants’ financial standing and risk levels based on their financial statements submitted to the Revenue Department for income tax filing as a significant factor for establishing loan limits
May 15, 2019 Subject: Notification of the resolution of the Board of Directors in relation to the approval of financial statements of the 1st quarter of fiscal year 2019 To: The President The Stock
instructed POLAR to conduct a special audit on the sources, existence and completeness of the accounting records and the disclosure in the financial statements of the liabilities whose material information